Melasyl: A Game Changer for All Skin Tones

Hyperpigmentation isn't experienced equally across all skin tones. The visibility, triggers, and treatment responses vary significantly based on your natural complexion and melanin concentration.

Understanding the Fitzpatrick Scale

The Fitzpatrick scale classifies skin into six phototypes based on how it responds to UV exposure and its natural melanin content:

Phototype I: Very fair skin that always burns, never tans. Minimal melanin production.

Phototype II: Fair skin that usually burns, tans minimally. Low melanin production.

Phototype III: Medium skin that sometimes burns, tans gradually. Moderate melanin production.

Phototype IV: Olive/light brown skin that rarely burns, tans easily. High melanin production.

Phototype V: Brown skin that very rarely burns, tans very easily. Very high melanin production.

Phototype VI: Dark brown/black skin that never burns, always deeply pigmented. Maximum melanin production.

How Hyperpigmentation Differs Across Skin Tones

Lighter Skin Tones (Phototypes I-III)

Fair to medium complexions most commonly develop sun spots and age spots from cumulative UV exposure. These skin tones show visible pigmentation contrast more dramatically—even small amounts of excess melanin create noticeable dark patches against lighter surrounding skin. The primary trigger is UV damage accumulated over years of sun exposure, with melanocytes becoming hyperactive in localized areas.

However, lighter skin tones typically respond faster to brightening treatments because there's less baseline melanin to regulate. Treatment results become visible more quickly, though prevention through rigorous SPF remains absolutely essential.

Medium Skin Tones (Phototypes III-IV)

Medium complexions frequently experience melasma and mixed pigmentation patterns, with hormonal triggers playing a prominent role. Pregnancy, birth control, and hormone replacement therapy can activate the melanocyte systemically, creating stubborn symmetrical patches across the face that prove notoriously difficult to treat.

These skin tones face a dual challenge: significant enough melanin production to create visible pigmentation, which means that minor trauma triggers immediate hyperpigmentation. UV exposure remains a critical factor, as these skin tones can develop both sun-induced and hormonally triggered pigmentation simultaneously.

Darker Skin Tones (Phototypes V-VI)

Dark and very dark skin tones are particularly prone to post-inflammatory hyperpigmentation (PIH). More active melanocytes mean even minor trauma—a small scratch, insect bite, or acne breakout—triggers more visible, longer-lasting pigmentation. This makes PIH the second most important concern in African American populations.*

The challenge for darker skin tones isn't just the prevalence of PIH—it's that pigmentation persists significantly longer without treatment. While a fair-skinned person might see PIH fade in 6-8 months, the same mark on darker skin can persist for 12 to 18 months or longer without targeted intervention.

Additionally, darker skin tones have historically been underrepresented in clinical studies, creating a knowledge gap where many brightening ingredients lacked robust efficacy data for phototypes V-VI. This makes clinically validated, inclusive solutions like Melasyl™ particularly significant.

Developing a brightening ingredient that works identically across all skin tones requires understanding fundamental melanin biology rather than targeting superficial signs.

Why Traditional Ingredients Fall Short

Most brightening actives work by inhibiting tyrosinase—the enzyme responsible for melanin synthesis. While this approach can be effective, the degree of efficacy varies based on baseline melanin production. Skin with naturally higher melanin concentrations (phototypes IV-VI) has more active tyrosinase, meaning the same concentration of inhibitor may deliver less dramatic visible results.

Additionally, many traditional brightening ingredients require careful formulation to avoid irritation on darker skin tones, where inflammation itself triggers additional pigmentation—creating a counterproductive cycle where the treatment intended to fade dark spots actually creates new ones.

The Melasyl™ Innovation: A Mechanism That Transcends Skin Tone

Melasyl™ works differently. Rather than inhibiting tyrosinase, it intercepts melanin precursors before they mark the skin. These precursors are molecules that, through enzymatic reactions, would eventually transform into colored melanin pigments.* By forming conjugates with melanin precursor metabolites—specifically dopaquinone, DHICA-quinone, and DHI-quinone—Melasyl™ prevents their integration into growing melanin.*

This mechanism is skin tone agnostic. Whether your melanocytes are producing small amounts of melanin (phototype I) or large amounts (phototype VI), Melasyl™ intercepts the same precursor molecules at the same stage in the pigmentation pathway. The biological process being targeted is identical across all complexions, making efficacy inherently universal.

L'Oréal Research didn't just claim universal efficacy—they validated it through rigorous clinical testing on diverse populations across all Fitzpatrick phototypes.

Comprehensive Study on Phototypes I-VI

One study demonstrated that 2-MNG prevents and decreases Ultraviolet-induced pigmentation and is effective across Fitzpatrick scale phototypes I-VI.* This wasn't a study focusing primarily on lighter skin with a small darker-skinned cohort included for appearance—it was designed from the outset to validate efficacy across the complete spectrum.

Clinical studies on human volunteers, across diverse skin tones, evaluated the anti-pigmentation efficacy of Melasyl™. Double-blind, randomized clinical studies tested formulations containing 0.5% and 1% 2-MNG against a vehicle control, demonstrating that Melasyl™ could prevent UV-induced immediate skin darkening and inhibit delayed tanning without adverse effects.*

Focused Studies on Medium to Dark Skin Tones

In a 3-month clinical study on Asian volunteers (Fitzpatrick scale Phototypes IV & V) and Chinese volunteers (Fitzpatrick scale Phototypes III), Melasyl™ 0.5% visibly decreased Ultraviolet-induced pigmentation by intercepting and delaying melanin formation.* This focused research on phototypes III-V—the range where many brightening ingredients show diminished efficacy—proved Melasyl™ delivers consistent results even on skin tones with naturally high melanin production.

Superior Performance Across All Actives

A meta-analysis indicated that 0.5% Melasyl™ provided statistically superior anti-pigmentation performance compared to a range of more than ten other recognized actives from the market, including vitamin C, kojic acid, niacinamide, and arbutin.* This head-to-head comparison wasn't conducted on a single skin tone—it validated superior efficacy across diverse populations, proving Melasyl™ outperforms traditional brightening ingredients regardless of your natural complexion.

L'Oréal Paris incorporated Melasyl™ into formulations designed for maximum accessibility and efficacy across all skin tones.

Clinical Testing on Diverse Populations

Testing on 70 women across phototypes I-VI delivered an impressive transformation. This wasn't testing that skewed toward lighter or darker skin—it intentionally included the full spectrum to validate universal efficacy.*

After 7 Days: Visible results in triple efficacy—improvements visible in dark spots, wrinkles, and dullness across all phototypes. Skin appears noticeably brighter and more radiant regardless of baseline complexion.

After 8 Weeks: 86% reduction in dark spots (clinically proven and notary certified).*

Consumer Experience: 97% felt their skin was comfortable all day long—crucial validation that the formula doesn't cause irritation that could trigger additional pigmentation on reactive skin.* 94% received compliments from others who spontaneously noticed their improved skin, the kind of visible transformation that transcends personal perception.*

The Complete Formula: Designed for All Skin

Revitalift Laser Melasyl Creamy-Serum combines Melasyl™ with complementary actives selected for universal tolerance and efficacy.

Complete 14% Derm-Grade Actives:

• Melasyl™ (2-Mercaptonicotinoyl Glycine): Intercepts melanin precursors identically across all skin tones
• Niacinamide: Reduces melanin transfer by 78% while providing anti-inflammatory benefits that prevent PIH—particularly crucial for phototypes IV-VI*
• Ascorbyl Glucoside (Vitamin Cg): Stable Vitamin C derivative, gentle enough for twice-daily use on all skin types, providing brightening and antioxidant defense
• Capryloyl Salicylic Acid (LHA): Exfoliates and removes dead skin cells to boost skin renewal
• Hydroxyethylpiperazine Ethane Sulfonic Acid (HEPES): Refines texture for improved radiance across all complexions
• Dipotassium Glycyrrhizate (Licorice Root Extract): Anti-inflammatory properties prevent the inflammatory triggers that create PIH in reactive skin*
• Glycerin: 100-hour hydration maintains optimal skin barrier function across all skin types

While Melasyl™'s mechanism works universally, different skin tones face distinct hyperpigmentation challenges that require a targeted understanding and approach.

Sun Spots on Fair Skin

Fair skin (phototypes I-II) shows sun damage most dramatically, with even small amounts of excess melanin creating visible contrast. Years of cumulative UV exposure surface as concentrated dark patches on the face, hands, and shoulders.

Melasyl™ prevents UV-induced immediate skin darkening and inhibits delayed tanning,* making it particularly effective for the sun-induced pigmentation that plagues fair complexions. Combined with mandatory daily SPF 50+, it creates dual defense: prevention of new spots while correcting existing damage.

Melasma on Medium Skin

Melasma—symmetrical brown patches triggered by hormones—affects 1 in 3 women in South America and Asia, predominantly those with phototypes III-IV. This notoriously stubborn condition worsens dramatically with sun exposure and resists many traditional treatments.

In a 3-month clinical study on Asian volunteers (Fitzpatrick scale Phototypes IV & V) and Chinese volunteers (Fitzpatrick scale Phototypes III), Melasyl™ 0.5% visibly decreased Ultraviolet-induced pigmentation by intercepting and delaying melanin formation.* This demonstrates effectiveness precisely on the skin tones most affected by melasma, offering hope for a condition that has historically been challenging to treat.

Post-Inflammatory Hyperpigmentation on Dark Skin

PIH is the second most important concern in African American populations, with darker skin tones experiencing more visible, longer-lasting pigmentation from even minor trauma.* The melanocytes in phototypes V-VI are naturally more reactive, meaning inflammation from acne, scratches, or irritation triggers more intense melanin production.

Melasyl™'s mechanism of intercepting melanin precursors works regardless of what triggered their production—whether UV exposure, hormonal changes, or inflammatory response.* Combined with niacinamide's anti-inflammatory properties and gentle exfoliating actives like LHA, the formula addresses PIH at multiple stages while preventing the irritation that could create additional dark spots.

Beyond the science, Melasyl™'s universal efficacy represents a fundamental shift in how the beauty industry approaches diversity and inclusion in product development.

Representation in Research

For decades, darker skin tones were underrepresented in clinical studies, creating a knowledge gap where efficacy claims were based primarily on lighter-skinned populations. This left millions of people with phototypes IV-VI uncertain whether products would actually work for them.

L'Oréal Research's commitment to testing Melasyl™ across the full Fitzpatrick scale from the beginning of clinical validation represents a fundamental shift. It acknowledges that true innovation means creating solutions that work for everyone—not just adapting formulas designed for fair skin and hoping they translate to darker complexions.

The Impact of Visible Spots

As Anne Colonna, Global Head of Advanced Research at L'Oréal Groupe, stated: "Half of all people report having skin pigmentation issues and a third of these experiencing lower quality of life as a result, the impact of visible spots is clearly more than skin-deep."*

This impact doesn't discriminate by skin tone. Whether you're phototype I experiencing sun spots or phototype VI dealing with post-acne marks, hyperpigmentation affects confidence, self-perception, and quality of life. A truly effective solution must address this concern universally—and Melasyl™ does exactly that with clinical validation across all complexions.

Regardless of your skin tone, successful hyperpigmentation management requires consistent application and non-negotiable sun protection. Here's how to optimize your routine based on your specific phototype.

The Universal Foundation

Regardless of your skin tone, successful hyperpigmentation management requires consistent application and non-negotiable sun protection.

Morning:

• Cleanse gently
• Apply Revitalift Laser Melasyl Creamy-Serum (2-3 drops pressed into skin)
• Follow with SPF 50+ broad-spectrum (essential for all phototypes—UV triggers pigmentation regardless of skin tone)

Evening:

• Double cleanse to remove SPF and impurities
• Apply Revitalift Laser Melasyl Creamy-Serum (skin repair peaks 10 PM-2 AM)
• Seal with night moisturizer

Melasyl™ represents more than a breakthrough brightening ingredient—it's proof that effective skincare can and should be genuinely inclusive. After 18 years of research and screening 100,000 molecules, L'Oréal Research identified a molecule whose mechanism transcends skin tone, delivering equal efficacy across the full Fitzpatrick scale.*

The clinical validation across phototypes I-VI wasn't an afterthought—it was fundamental to the research design, acknowledging that true innovation means creating solutions that work for everyone. Testing on diverse populations demonstrated 86% dark spot reduction in 8 weeks, visible brightening within 7 days, and 97% comfort across all skin tones.*

For fair skin struggling with sun spots, medium skin battling melasma, or dark skin dealing with post-inflammatory hyperpigmentation, Melasyl™ offers the same promise: scientifically validated correction that respects your natural complexion while addressing excess pigmentation with proven efficacy.

Your journey to visibly more even-toned skin doesn't depend on your phototype—it depends on choosing solutions backed by inclusive science. Melasyl™ isn't just a game changer for all skin tones—it's setting a new standard for what truly universal efficacy means in skincare.

References

• De Dormael, R., Sextius, P., Bourokba, N., Mainguene, E., Tachon, R., Kumar, G., Jouni, H., ... & Diridollou, S. (2024). 2-MERCAPTONICOTINOYL GLYCINE, A NEW MOLECULE THAT PREVENTS AND DECREASES UV-INDUCED PIGMENTATION. 25th World Congress of Dermatology (WCD) 2023. [Scientific Poster]
• Prévot-Guéguiniat, A., Sextius, P., Lereaux, G., Warrick, E., Ben Hassine, S., Baux, L., ... & Marat, X. (2024). DISCOVERY OF 2-MERCAPTONICOTINOYL GLYCINE: A NEW POTENT BRIGHTENING AGENT FOR HYPERPIGMENTATION MANAGEMENT, EXHIBITING A LOW ENVIRONMENTAL IMPACT. 25th World Congress of Dermatology (WCD) 2023. [Scientific Poster]
• Sextius, P., De Dormael, R., Prévot Guéguiniat, A., Lereaux, G., Warrick, E., & Diridollou, S. (2024). 2-MERCAPTONICOTINOYL GLYCINE, A POTENT BRIGHTENING AGENT EXHIBITING A UNIQUE MODE OF ACTION INVESTIGATED IN VITRO & IN VIVO. 25th World Congress of Dermatology (WCD) 2023. [Scientific Poster]
• L'Oréal Paris. (n.d.). The Science Behind Melasyl™: Our Strongest Brightening Active Ever. [Scientific Dossier]
• Prevot-Gueguiniat, A., Sextius, P., Lereaux, G., Tachon, R., Mainguene, E., Tricaud, C., Diridollou, S., & Marat, X. (2024). Discovery of 2-mercaptonicotinoyl glycine, a new potent brightening agent for hyperpigmentation management. International Journal of Cosmetic Science, 46(2), 241-249. doi: 10.1111/ics.12933. [PubMed: 38433524]
• De Dormael, R., Sextius, P., Bourokba, N., Mainguene, E., Tachon, R., Kumar, G., Jouni, H., & Diridollou, S. (2024). 2-mercaptonicotinoyl glycine prevents UV-induced skin darkening and delayed tanning. International Journal of Cosmetic Science, 46(2), 250-258. doi: 10.1111/ics.12932. [PubMed: 38560773]
• L'Oréal Groupe Press Release, "L'Oréal Groupe Launches Melasyl™, A Groundbreaking Ingredient to Address Localized Skin Pigmentation Issues," March 11, 2024.